Omakase

About Omakase

This author has not yet filled in any details.
So far Omakase has created 83 blog entries.

This week, from 20th to 22nd October, takes place the 65th National Congress of Spanish Society of Hospital Pharmacy, 100% online for the first time. This edition will include several chats about timeliness topics such as experiences about Horizon Scanning of Orphan Drugs and MCDA methodology that will be shared by Dr. Badía, CEO Omakase Consulting.
This week, from 20th to 22nd October, takes place the 65th National Congress of Spanish Society of Hospital Pharmacy, 100% online for the first time. This edition will include several chats about timeliness topics such as experiences about Horizon Scanning of Orphan Drugs and MCDA methodology that will be shared by Dr. Badía, CEO Omakase Consulting.

This week, from 20th to 22nd October, takes place the 65th National Congress of Spanish Society of Hospital Pharmacy, 100% online for the first time. This edition will include several chats about timeliness topics such as experiences about Horizon Scanning of Orphan Drugs and MCDA methodology that will be shared by Dr. Badía, CEO Omakase Consulting.

Omakase2020-10-19T16:23:34+00:00October 19th, 2020|News & Events|

Check the full program in the following link: https://65congreso.sefh.es/program [...]

Proud to be a co-author in the article “Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the experts” published today in the Spanish Journal of Gastroenterology.
Proud to be a co-author in the article “Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the experts” published today in the Spanish Journal of Gastroenterology.

Proud to be a co-author in the article “Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the experts” published today in the Spanish Journal of Gastroenterology.

Omakase2020-10-08T12:04:18+00:00October 8th, 2020|News & Events|

The article is based on research, first of its kind in Spain, involving 32 gastr [...]

Omakase Consulting has participated in a meeting to present the Roadmap in immunotherapy applied to oncology (Horizon 2022) to Patricia Lacruz and other members from her team in the General Direction of Pharmacy (DGF) of the Spanish Ministry of Health.
Omakase Consulting has participated in a meeting to present the Roadmap in immunotherapy applied to oncology (Horizon 2022) to Patricia Lacruz and other members from her team in the General Direction of Pharmacy (DGF) of the Spanish Ministry of Health.

Omakase Consulting has participated in a meeting to present the Roadmap in immunotherapy applied to oncology (Horizon 2022) to Patricia Lacruz and other members from her team in the General Direction of Pharmacy (DGF) of the Spanish Ministry of Health.

Omakase2020-10-07T09:22:51+00:00October 6th, 2020|News & Events|

Omakase Consulting has participated in a meeting to present the Roadmap in immun [...]

Editorial Committee of EDS Journal has met to define economy and healthcare policy as new action lines of content in the following publications, focusing on breaking news, experiences and key topics in healthcare environment
Editorial Committee of EDS Journal has met to define economy and healthcare policy as new action lines of content in the following publications, focusing on breaking news, experiences and key topics in healthcare environment

Editorial Committee of EDS Journal has met to define economy and healthcare policy as new action lines of content in the following publications, focusing on breaking news, experiences and key topics in healthcare environment

Omakase2020-09-28T16:18:16+00:00September 28th, 2020|News & Events|

https://gacetamedica.com/politica/el-comite-editorial-de-eds-marca-la-hoja-de-ru [...]

The June 2020 summary of P&R decisions from the Spanish Interministerial Medicinal Products Pricing Committee (CIPM) is now translated and available to download in English.
The June 2020 summary of P&R decisions from the Spanish Interministerial Medicinal Products Pricing Committee (CIPM) is now translated and available to download in English.

The June 2020 summary of P&R decisions from the Spanish Interministerial Medicinal Products Pricing Committee (CIPM) is now translated and available to download in English.

Omakase2020-09-22T12:45:52+00:00September 22nd, 2020|News & Events|

Download the translated version here: https: https://www.omakaseconsulting.com/t [...]

The influence of a positive Therapeutic Positioning Report (TPR/IPT) to shorten P&R process up to 5 months for Orphan Drugs in Spain
The influence of a positive Therapeutic Positioning Report (TPR/IPT) to shorten P&R process up to 5 months for Orphan Drugs in Spain

The influence of a positive Therapeutic Positioning Report (TPR/IPT) to shorten P&R process up to 5 months for Orphan Drugs in Spain

Omakase2020-09-08T16:13:42+00:00September 8th, 2020|News & Events|

https://elglobal.es/politica/el-ipt-clave-para-que-un-medicamento-huerfano-recib [...]

The March 2020 summary of P&R decisions in Spain is now available for downloading

Omakase2020-09-04T12:00:15+00:00June 30th, 2020|P&R Committee Resolutions (CIMP)|

The February 2020 summary of P&R decisions from the Spanish Interministeria [...]

The February 2020 summary of P&R decisions in Spain is now available for downloading

Omakase2020-09-08T15:23:52+00:00March 9th, 2020|P&R Committee Resolutions (CIMP)|

The February 2020 summary of P&R decisions from the Spanish Interministerial [...]

NewsRARE Journal: MCDA methodology, an alternative model for the evaluation of new orphan drugs

Omakase2020-09-08T15:24:21+00:00February 28th, 2020|News & Events|

Now available the 5th new edition of NewsRARE Journal, including an editorial fr [...]

The October 2019 summary of P&R decisions in Spain is now available for downloading

Omakase2020-09-03T18:13:18+00:00December 16th, 2019|P&R Committee Resolutions (CIMP)|

The October 2019 summary of P&R decisions from the Spanish Interministerial [...]

Load More Posts

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the aforementioned cookies and the acceptance of our cookies policy, Click on the link for more information. ACEPTAR

Aviso de cookies